approval
saveGLATOPA (GLATIRAMER ACETATE) — FDA approval
community read0 votes
Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalFeb 12, 2026 · 237d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalFeb 12, 2026 · 237d ago
- approvalGLATIRAMER ACETATE — FDA approvalFeb 11, 2026 · 238d ago
- approvalGLATIRAMER ACETATE — FDA approvalFeb 11, 2026 · 238d ago
- approvalGLATIRAMER ACETATE — FDA approvalDec 31, 2025 · 280d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 7, 2025 · 579d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 7, 2025 · 579d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 19, 2024 · 932d ago
same company · ±60 days · 6
- approvalZOLEDRONIC ACID: RECLAST (ZOLEDRONIC ACID) — FDA approvalApr 16, 2015
- approvalRITALIN LA: RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalApr 17, 2015
- approvaldexmethylphenidate hydrochloride ER: FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvalApr 17, 2015
- approvalUNASYN: AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalMar 1, 2015
- approvalUNASYN: AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalMar 1, 2015
- approvalRITALIN LA: RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJun 2, 2015
comments(0)
5-min edit window · permanent after that